Schenkein was previously chief executive officer of Agios Pharmaceuticals, which he grew from a small closely held startup to a $3.1 billion biotechnology company
from RSS Feeds : RSS Feed - NDTV Gadgets360.com http://bit.ly/2BsSxDa
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment